SiliconInvestor
     Advanced Search   [ sign in ]

register
Register

 Biotech / Medical : COB Columbia Laboratories

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: cfoe who wrote (631)1/15/2003 9:23:21 PM
From: wolfdog2Read Replies (1) of 634
 
cfoe, I think it's worth holding. Wilkenson, the ceo, seems to be turning this into a real company. Their male testosterone product should get the nod from the FDA by mid year. The stock is, imo, worth more than its current price for the testosterone product alone.

Meanwhile COB has a new salesforce marketing C8%, miPhil and Advantage S to obgns. SRA, as you may know also markets C8% to fertility clinics. COB is also testing their delivery system for use in delivery of small molecule peptides. Desmopressin is the first one. In addition, they are now developing Chronodyne with a European partner. They have another product in development as well.

Hope this helps.
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.